Tag: gene therapy

Genprex begins dosing of phase 1/2 trial of REQORSA, Tagrisso combo

businessnewstoday- March 6, 2022 0

Genprex has dosed the first patient in the Acclaim-1 phase 1/2 clinical trial of REQORSA immunogene therapy candidate in combination with Tagrisso (osimertinib) in a ... Read More

Oxford Biomedica, Homology Medicines to create AAV manufacturing JV in US

businessnewstoday- January 31, 2022 0

Oxford Biomedica, a UK-based gene and cell therapy company, has agreed to form a joint venture (JV) to undertake an adeno-associated virus (AAV) manufacturing and ... Read More

Novartis to acquire ocular gene therapy company Gyroscope Therapeutics

businessnewstoday- January 3, 2022 0

Novartis has agreed to acquire Gyroscope Therapeutics, a UK-based ocular gene therapy company, in a deal worth up to $1.5 billion. As per the terms ... Read More

Ocugen gets FDA nod to begin OCU400 clinical trial in retinitis pigmentosa

businessnewstoday- December 11, 2021 0

Ocugen said that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) to launch a first-in-human clinical trial of ... Read More

FDA puts clinical hold on Selecta Biosciences SEL-302 phase 1/2 trial

businessnewstoday- November 27, 2021 0

Selecta Biosciences said that the US Food and Drug Administration (FDA) has imposed a clinical hold on its phase 1/2 clinical trial of SEL-302 gene ... Read More

Vivet’s VTX-801 gene therapy gets FDA fast track status in Wilson Disease

businessnewstoday- August 14, 2021 0

Vivet Therapeutics, a biotech company backed by Pfizer, has been given fast track designation by the US Food and Drug Administration for its gene therapy ... Read More

Charles River Laboratories to acquire gene therapy CDMO Vigene Biosciences

businessnewstoday- May 19, 2021 0

Charles River Laboratories International has signed an all-cash deal worth $292.5 million to acquire Vigene Biosciences, a US-based gene therapy contract development and manufacturing organization ... Read More

Lilly wraps up acquisition of gene therapy company Prevail Therapeutics

pharmanewsdaily- January 23, 2021 0

Eli Lilly and Company (Lilly) has completed its previously announced deal worth up to $1.04 billion of US gene therapy company Prevail Therapeutics. The US ... Read More

Lilly to acquire US gene therapy company Prevail Therapeutics in $1bn deal

pharmanewsdaily- December 16, 2020 0

Eli Lilly and Company (Lilly) has signed a deal worth up to $1.04 billion to acquire Prevail Therapeutics, a US gene therapy company engaged in ... Read More

Novartis acquires optogenetics gene therapy company Vedere Bio

pharmanewsdaily- October 29, 2020 0

Novartis acquisition of Vedere Bio : US-based stealth-stage company Vedere Bio has been acquired by Swiss pharma giant Novartis in a deal worth up to ... Read More